Candriam Equities L Oncology Impact R/ LU1864482861 /
| NAV2024-04-18 | Chg.-0.5600 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 180.1100USD | -0.31% | paying dividend | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | -1.46 | -5.36 | -3.08 | 12.11 | 8.53 | 1.40 | 4.43 | 2.14 | 3.50 | -2.21 | 5.80 | 3.85 | +32.28% |
| 2021 | 0.54 | -4.21 | -0.10 | 2.32 | 0.17 | 3.52 | -0.97 | 5.58 | -3.78 | 3.36 | -6.38 | 3.98 | +3.34% |
| 2022 | -10.50 | -1.76 | 4.64 | -5.86 | -1.34 | 0.04 | 4.36 | -3.15 | -4.72 | 7.03 | 6.07 | -3.45 | -9.76% |
| 2023 | 2.15 | -3.89 | 1.37 | 2.82 | -2.57 | 0.07 | 0.88 | -2.02 | -5.25 | -6.36 | 9.21 | 5.72 | +1.01% |
| 2024 | 1.36 | 4.14 | 1.48 | -6.37 | - | - | - | - | - | - | - | - | - |
Single months: Dividends not considered
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 10.93% | 12.73% | 11.88% | 14.74% | -% |
| Sharpe ratio | -0.26 | 1.66 | -0.47 | -0.34 | - |
| Best month | +5.72% | +9.21% | +9.21% | +9.21% | +12.11% |
| Worst month | -6.37% | -6.37% | -6.37% | -10.50% | -10.50% |
| Maximum loss | -6.79% | -6.79% | -16.64% | -25.23% | - |
| Outperformance | - | - | - | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,215.3799 | -1.24% | -2.07% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,367.0300 | -1.11% | -1.70% | |
| Candriam Equities L Oncology Imp... | reinvestment | 192.3800 | -4.57% | -12.11% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,116.2300 | -1.69% | +9.02% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,495.0601 | -1.55% | -3.01% | |
| Candriam Equities L Oncology Imp... | reinvestment | 231.2700 | +0.33% | +6.37% | |
| Candriam Equities L Oncology Imp... | paying dividend | 222.6300 | -2.48% | -5.69% | |
| Candriam Equities L Oncology Imp... | paying dividend | 180.1100 | -1.64% | -3.29% | |
| Candriam Equities L Oncology Imp... | paying dividend | 19,777.0000 | -4.48% | -4.95% | |
| Candriam Equities L Oncology Imp... | reinvestment | 149.7300 | -1.80% | +8.66% | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,954.4700 | -3.66% | -9.59% | |
| Candriam Equities L Oncology Imp... | reinvestment | 244.8700 | +1.19% | +9.08% | |
| Candriam Equities L Oncology Imp... | reinvestment | 191.9700 | -4.95% | -13.14% | |
| Candriam Equities L Oncology Imp... | reinvestment | 264.8100 | -1.65% | -3.30% | |
| Candriam Equities L Oncology Imp... | reinvestment | 179.5200 | -3.77% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,745.0500 | -1.37% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,661.9299 | -1.55% | -3.01% | |
| Candriam Equities L Oncology Imp... | reinvestment | 148.7500 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 253.5600 | -2.48% | -5.71% |
Performance
| YTD | +0.30% | ||
|---|---|---|---|
| 6 Months | +11.77% | ||
| 1 Year | -1.64% | ||
| 3 Years | -3.29% | ||
| 5 Years | - | ||
| Since start | +26.26% | ||
| Year | |||
| 2023 | +1.01% | ||
| 2022 | -9.76% | ||
| 2021 | +3.34% | ||
| 2020 | +32.28% | ||
Dividends
| 2023-04-28 | 2.69 USD |
| 2022-04-28 | 3.36 USD |
| 2021-04-28 | 3.25 USD |
